{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T17:29:13Z","timestamp":1790962153961,"version":"4.1.0"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,2]],"date-time":"2022-02-02T00:00:00Z","timestamp":1643760000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Regulatory Toxicology and Pharmacology"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.yrtph.2022.105128","type":"journal-article","created":{"date-parts":[[2022,1,29]],"date-time":"2022-01-29T17:33:19Z","timestamp":1643477599000},"page":"105128","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Benchmarking performance of SENS-IS assay against weight of evidence skin sensitization potency categories"],"prefix":"10.1016","volume":"130","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6708-7364","authenticated-orcid":false,"given":"Mihwa","family":"Na","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devin","family":"O'Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. Frank","family":"Gerberick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra S.","family":"Kern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maura","family":"Lavelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Parakhia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cindy","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Marie","family":"Api","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yrtph.2022.105128_bib1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.yrtph.2007.10.008","article-title":"Dermal sensitization quantitative risk assessment (QRA) for fragrance ingredients","volume":"52","author":"Api","year":"2008","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2022.105128_bib2","doi-asserted-by":"crossref","first-page":"298","DOI":"10.3109\/15569527.2014.979425","article-title":"Correlation between experimental human and murine skin sensitization induction thresholds","volume":"34","author":"Api","year":"2015","journal-title":"Cutan. Ocul. Toxicol."},{"key":"10.1016\/j.yrtph.2022.105128_bib3","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/DER.0000000000000304","article-title":"Fragrances categorized according to relative human skin sensitization potency","volume":"28","author":"Api","year":"2017","journal-title":"Dermatitis"},{"key":"10.1016\/j.yrtph.2022.105128_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2020.104805","article-title":"Updating exposure assessment for skin sensitization quantitative risk assessment for fragrance materials","volume":"118","author":"Api","year":"2020","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2022.105128_bib5","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/(SICI)1099-1263(199907\/08)19:4<261::AID-JAT572>3.0.CO;2-5","article-title":"A comparison of statistical approaches to the derivation of EC3 values from local lymph node assay dose responses","volume":"19","author":"Basketter","year":"1999","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.yrtph.2022.105128_bib6","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/j.1600-0536.1999.tb06013.x","article-title":"Skin sensitization risk assessment: a comparative evaluation of 3 isothiazolinone biocides","volume":"40","author":"Basketter","year":"1999","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.yrtph.2022.105128_bib7","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.1600-0536.2007.01141.x","article-title":"The local lymph node assay and the assessment of relative potency: status of validation","volume":"57","author":"Basketter","year":"2007","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.yrtph.2022.105128_bib8","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/DER.0000000000000003","article-title":"Categorization of chemicals according to their relative human skin sensitizing potency","volume":"25","author":"Basketter","year":"2014","journal-title":"Dermatitis"},{"key":"10.1016\/j.yrtph.2022.105128_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.tiv.2020.104781","article-title":"In vitro testing strategy for assessing the skin sensitizing potential of \"difficult to test\" cosmetic ingredients","volume":"65","author":"Bergal","year":"2020","journal-title":"Toxicol. Vitro"},{"key":"10.1016\/j.yrtph.2022.105128_bib10","doi-asserted-by":"crossref","first-page":"187S","DOI":"10.1177\/1091581810374651","article-title":"Final report of the safety assessment of methylisothiazolinone","volume":"29","author":"Burnett","year":"2010","journal-title":"Int. J. Toxicol."},{"key":"10.1016\/j.yrtph.2022.105128_bib11","doi-asserted-by":"crossref","first-page":"77S","DOI":"10.1177\/1091581812447202","article-title":"Final report of the cosmetic ingredient review expert panel on the safety assessment of cocamidopropyl betaine (CAPB)","volume":"31","author":"Burnett","year":"2012","journal-title":"Int. J. Toxicol."},{"key":"10.1016\/j.yrtph.2022.105128_bib12","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/bjc.1979.10","article-title":"Describing the validity of carcinogen screening tests","volume":"39","author":"Cooper","year":"1979","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.yrtph.2022.105128_bib13","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.tiv.2015.02.012","article-title":"Genes specifically modulated in sensitized skins allow the detection of sensitizers in a reconstructed human skin model. Development of the SENS-IS assay","volume":"29","author":"Cottrez","year":"2015","journal-title":"Toxicol. Vitro"},{"key":"10.1016\/j.yrtph.2022.105128_bib14","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.tiv.2016.01.007","article-title":"SENS-IS, a 3D reconstituted epidermis based model for quantifying chemical sensitization potency: reproducibility and predictivity results from an inter-laboratory study","volume":"32","author":"Cottrez","year":"2016","journal-title":"Toxicol. Vitro"},{"key":"10.1016\/j.yrtph.2022.105128_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.tiv.2019.104644","article-title":"In vitro measurement of skin sensitization hazard of mixtures and finished products: results obtained with the SENS-IS assays","volume":"62","author":"Cottrez","year":"2020","journal-title":"Toxicol. Vitro"},{"key":"10.1016\/j.yrtph.2022.105128_bib16","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1111\/j.1365-2133.2007.08162.x","article-title":"The relationships between exposure dose and response in induction and elicitation of contact hypersensitivity in humans","volume":"157","author":"Friedmann","year":"2007","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.yrtph.2022.105128_bib17","first-page":"156","article-title":"Contact allergenic potency: correlation of human and local lymph node assay data","volume":"12","author":"Gerberick","year":"2001","journal-title":"Am. J. Contact Dermatitis"},{"key":"10.1016\/j.yrtph.2022.105128_bib18","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.0105-1873.2004.00290.x","article-title":"A chemical dataset for evaluation of alternative approaches to skin-sensitization testing","volume":"50","author":"Gerberick","year":"2004","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.yrtph.2022.105128_bib19","first-page":"157","article-title":"Compilation of historical local lymph node data for evaluation of skin sensitization alternative methods","volume":"16","author":"Gerberick","year":"2005","journal-title":"Dermatitis"},{"key":"10.1016\/j.yrtph.2022.105128_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2020.104721","article-title":"Development of a next generation risk assessment framework for the evaluation of skin sensitisation of cosmetic ingredients","volume":"116","author":"Gilmour","year":"2020","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2022.105128_bib21","first-page":"54","article-title":"Cutaneous safety of fragrance material as measured by the maximization test","volume":"82","author":"Greif","year":"1967","journal-title":"Am Perfumer Cosmet"},{"key":"10.1016\/j.yrtph.2022.105128_bib22","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.yrtph.2003.07.001","article-title":"Proposal for a risk assessment methodology for skin sensitization based on sensitization potency data","volume":"38","author":"Griem","year":"2003","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2022.105128_bib23","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1093\/toxsci\/kft080","article-title":"Use of human in vitro skin models for accurate and ethical risk assessment: metabolic considerations","volume":"133","author":"Hewitt","year":"2013","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.yrtph.2022.105128_bib24","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1002\/jat.3105","article-title":"Evaluation of combinations of in vitro sensitization test descriptors for the artificial neural network-based risk assessment model of skin sensitization","volume":"35","author":"Hirota","year":"2015","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.yrtph.2022.105128_bib25","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1002\/jat.3558","article-title":"Development of an artificial neural network model for risk assessment of skin sensitization using human cell line activation test, direct peptide reactivity assay, KeratinoSens and in silico structure alert parameter","volume":"38","author":"Hirota","year":"2018","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.yrtph.2022.105128_bib26","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1080\/10408444.2018.1429385","article-title":"Non-animal methods to predict skin sensitization (I): the Cosmetics Europe database<sup\/&gt","volume":"48","author":"Hoffmann","year":"2018","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.yrtph.2022.105128_bib27","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1007\/s00204-015-1634-2","article-title":"Bayesian integrated testing strategy (ITS) for skin sensitization potency assessment: a decision support system for quantitative weight of evidence and adaptive testing strategy","volume":"89","author":"Jaworska","year":"2015","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.yrtph.2022.105128_bib28","doi-asserted-by":"crossref","first-page":"8","DOI":"10.2310\/6620.2009.09038","article-title":"Local lymph node data for the evaluation of skin sensitization alternatives: a second compilation","volume":"21","author":"Kern","year":"2010","journal-title":"Dermatitis"},{"key":"10.1016\/j.yrtph.2022.105128_bib29","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.yrtph.2008.01.010","article-title":"Dose metrics in the acquisition of skin sensitization: thresholds and importance of dose per unit area","volume":"52","author":"Kimber","year":"2008","journal-title":"Regul. Toxicol. Pharmacol."},{"issue":"Suppl. 1","key":"10.1016\/j.yrtph.2022.105128_bib30","doi-asserted-by":"crossref","first-page":"S238","DOI":"10.1093\/toxsci\/kfq346","article-title":"Chemical allergy: translating biology into hazard characterization","volume":"120","author":"Kimber","year":"2011","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.yrtph.2022.105128_bib31","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1080\/10408444.2018.1429386","article-title":"Non-animal methods to predict skin sensitization (II): an assessment of defined approaches (*)","volume":"48","author":"Kleinstreuer","year":"2018","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.yrtph.2022.105128_bib32","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/jid.1966.160","article-title":"The identification of contact allergens by human assay. 3. The maximization test: a procedure for screening and rating contact sensitizers","volume":"47","author":"Kligman","year":"1966","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.yrtph.2022.105128_bib59","article-title":"A matched molecular pair (MMP) approach for selecting analogs suitable for structure activity relationship (SAR)-based read across","volume":"104966","author":"Lester","year":"2021","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2022.105128_bib33","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1600-0536.1977.tb03674.x","article-title":"Contact sensitization to benzoyl peroxide","volume":"3","author":"Leyden","year":"1977","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.yrtph.2022.105128_bib34","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.yrtph.2009.08.016","article-title":"Potency values from the local lymph node assay: application to classification, labelling and risk assessment","volume":"56","author":"Loveless","year":"2010","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2022.105128_bib35","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0015-6264(74)90367-8","article-title":"The use of graded concentrations in studying skin sensitizers: experimental contact sensitization in man","volume":"12","author":"Marzulli","year":"1974","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.yrtph.2022.105128_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0536.1976.tb02972.x","article-title":"Contact allergy: predictive testing in man","volume":"2","author":"Marzulli","year":"1976","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.yrtph.2022.105128_bib37","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1600-0536.1980.tb03921.x","article-title":"Further studies of effects of vehicles and elicitation concentration in experimental contact sensitization testing in humans","volume":"6","author":"Marzulli","year":"1980","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.yrtph.2022.105128_bib38","series-title":"Weight of Evidence Approach for Skin Sensitization Potency Categorization of Fragrance Ingredients Dermatitis","author":"Na","year":"2021"},{"key":"10.1016\/j.yrtph.2022.105128_bib39","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1093\/toxsci\/kfu229","article-title":"Predicting skin sensitizer potency based on in vitro data from KeratinoSens and kinetic peptide binding: global versus domain-based assessment","volume":"143","author":"Natsch","year":"2015","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.yrtph.2022.105128_bib40","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1093\/toxsci\/kfy135","article-title":"Deriving a No expected sensitization induction level for fragrance ingredients without animal testing: an integrated approach applied to specific case studies","volume":"165","author":"Natsch","year":"2018","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.yrtph.2022.105128_bib41","series-title":"Test No. 429","year":"2010"},{"key":"10.1016\/j.yrtph.2022.105128_bib42","series-title":"The Adverse Outcome Pathway for Skin Sensitisation Initiated by Covalent Binding to Proteins","year":"2014"},{"key":"10.1016\/j.yrtph.2022.105128_bib43","series-title":"In Vitro Skin Sensitisation: ARE-Nrf2 Luciferase Test Method","article-title":"Test No. 442D","year":"2018"},{"key":"10.1016\/j.yrtph.2022.105128_bib44","series-title":"In Vitro Skin Sensitisation: in Vitro Skin Sensitisation Assays Addressing the Key Event on Activation of Dendritic Cells on the Adverse Outcome Pathway for Skin Sensitisation","article-title":"Test No. 442E","year":"2018"},{"key":"10.1016\/j.yrtph.2022.105128_bib45","series-title":"Test No. 442C: in Chemico Skin Sensitisation","year":"2020"},{"key":"10.1016\/j.yrtph.2022.105128_bib46","series-title":"Guideline No. 497: Defined Approaches on Skin Sensitisation","year":"2021"},{"key":"10.1016\/j.yrtph.2022.105128_bib47","series-title":"Supporting Document to the OECD Guideline 497 on Defined Approaches for Skin Sensitisation","year":"2021"},{"key":"10.1016\/j.yrtph.2022.105128_bib48","series-title":"Test No. 442C: in Chemico Skin Sensitisation","year":"2021"},{"key":"10.1016\/j.yrtph.2022.105128_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.tiv.2020.105068","article-title":"Pre-validation of SENS-IS assay for in vitro skin sensitization of medical devices","volume":"71","author":"Pellevoisin","year":"2021","journal-title":"Toxicol. Vitro"},{"key":"10.1016\/j.yrtph.2022.105128_bib50","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1034\/j.1600-0536.2000.043002095.x","article-title":"Activity of human contact allergens in the murine local lymph node assay","volume":"43","author":"Ryan","year":"2000","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.yrtph.2022.105128_bib51","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.yrtph.2004.02.002","article-title":"Quantitative relationship between the local lymph node assay and human skin sensitization assays","volume":"39","author":"Schneider","year":"2004","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2022.105128_bib58","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1021\/acs.chemrestox.9b00518","article-title":"Clustering a Chemical Inventory for Safety Assessment of Fragrance Ingredients: Identifying Read-Across Analogs to Address Data Gaps","volume":"33","author":"Date","year":"2020","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.yrtph.2022.105128_bib52","series-title":"Contact Sensitization: Classification According to Potency Technical Report No. 87","year":"2003"},{"key":"10.1016\/j.yrtph.2022.105128_bib53","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1002\/jat.3127","article-title":"Test battery with the human cell line activation test, direct peptide reactivity assay and DEREK based on a 139 chemical data set for predicting skin sensitizing potential and potency of chemicals","volume":"35","author":"Takenouchi","year":"2015","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.yrtph.2022.105128_bib54","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.yrtph.2014.12.008","article-title":"Assessing skin sensitization hazard in mice and men using non-animal test methods","volume":"71","author":"Urbisch","year":"2015","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2022.105128_bib55","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.tiv.2017.08.015","article-title":"Prediction of skin sensitization potency sub-categories using peptide reactivity data","volume":"45","author":"Wareing","year":"2017","journal-title":"Toxicol. Vitro"},{"key":"10.1016\/j.yrtph.2022.105128_bib56","doi-asserted-by":"crossref","first-page":"539","DOI":"10.14573\/altex.1701101","article-title":"The GARD platform for potency assessment of skin sensitizing chemicals","volume":"34","author":"Zeller","year":"2017","journal-title":"ALTEX"}],"container-title":["Regulatory Toxicology and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230022000150?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230022000150?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T12:32:51Z","timestamp":1759494771000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0273230022000150"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":58,"alternative-id":["S0273230022000150"],"URL":"https:\/\/doi.org\/10.1016\/j.yrtph.2022.105128","relation":{},"ISSN":["0273-2300"],"issn-type":[{"value":"0273-2300","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Benchmarking performance of SENS-IS assay against weight of evidence skin sensitization potency categories","name":"articletitle","label":"Article Title"},{"value":"Regulatory Toxicology and Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yrtph.2022.105128","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"105128"}}